Synergistic Effects of 9.2.27PE Immunotoxin and ABT-737 in Melanoma
Author Information
Author(s): Karianne Risberg, Øystein Fodstad, Yvonne Andersson
Primary Institution: Oslo University Hospital Radiumhospitalet
Hypothesis
Combining the 9.2.27PE immunotoxin with ABT-737 will achieve synergistic cytotoxicity in melanoma cells.
Conclusion
The combination of 9.2.27PE and ABT-737 caused strong synergistic cytotoxic effects in melanoma cells and delayed tumor growth in a mouse model.
Supporting Evidence
- The combination treatment caused a cytostatic effect on the growth of human melanoma xenograft in mice.
- The study showed that the combination of 9.2.27PE and ABT-737 resulted in synergistic cytotoxicity in melanoma cells.
- Increased intracellular calcium levels were observed with the combination treatment.
Takeaway
Using two special medicines together can help kill more cancer cells than using them alone.
Methodology
The study involved in vitro assays on melanoma cell lines and in vivo experiments on mice with melanoma xenografts.
Limitations
The study primarily focused on in vitro and xenograft models, which may not fully represent human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website